Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metaross G 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Bhumi Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Metaross G 2mg/500mg Tablet

Diabex Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer Diabex Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize hypoglycemia symptoms like sweating, dizziness, headache, and trembling, and know how to counteract them. Consistent meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a potential side effect. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Metaross G 2mg/500mg Tablet

The information is unavailable.

Uses of Metaross G 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Metaross G 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metaross G 2mg/500mg Tablet should be administered with a meal.

Common Side effects of Metaross G 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metaross G 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metaross G 2mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Metaross G 2mg/500mg Tablet works:

Each Metaross G 2mg/500mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), both acting to manage blood sugar. Glimepiride stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin's action is threefold: it decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Metaross G 2mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metaross G 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers before prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Use of Metaross G 2mg/500mg tablets is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms appear.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metaross G 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For individuals with severe kidney disease, Metaross G 2mg/500mg tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Metaross G 2mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Metaross G 2mg/500mg Tablet :

Should you forget to take your Metaross G 2mg/500mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Metaross G 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Metaross G 2mg/500mg Tablet

Store this medication in its original, tightly sealed container or packaging. Follow the storage directions on the container or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Metaross G 2mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is a rare but potentially harmful side effect, particularly for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may include muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If any of these symptoms appear, discontinue Metaross G 2mg/500mg Tablet use and seek immediate medical attention.
Glimepiride/Metformin 2mg/500mg tablets (e.g., Metaross G) combine two diabetes medications to manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin sensitivity. This combination therapy is unsuitable for type 1 diabetes management.
Metaross G 2mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged use of Metaross G 2mg/500mg Tablets can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Indeed, Metaross G 2mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Metaross G 2mg/500mg tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Metaross G 2mg/500mg Tabl...
59
MRP 72
17% off